Researchers cite ten-company drug-discovery model to argue biomanufacturers should pool data
Roger Hart and Kelvin Lee cite a model ten drug makers trained on 2.6 billion pooled data points as the case for sharing data across biomanufacturing. Its gains were measured on drug-discovery assays, so the payoff on plant data is untested.
Reality
- Evidence40
- Adoption20
- Hype gap+35
- Incentives50
- Confidence40